PRODUCTS

INTERNATIONAL  /  IBANDRONATE 150MG «  BACK TO "INTERNATIONAL"

Ibandronate belongs to the bisphosphonate group of compounds which act specifically on bone.

Ibadronate 150mg is indicated for the treatment and prevention of osteoporosis.
Active ingredient Pharmaceutical form Package Therapeutic target
  • Ibandronate 150mg
  • F.c. Tablets ONCE A MONTH
  • 150mg
  • Bone Metabolism-Osteoporosis

Other products in "International"